M. Singh
Impact in
-
- Nanoparticles: synthesis and applications
- Advanced Nanomaterials in Catalysis
Papers in
-
- Cholinesterase and Neurodegenerative Diseases 2
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 1
- Co-authors
- Saurabh R Prasad (1 shared paper)P.C. Pándey (3 shared papers)R. Peter Alston (1 shared paper)Masabumi Nagashima (1 shared paper)Yoshiro Inoue (1 shared paper)Alok Kumar Singh (3 shared papers)H. S. Shukla (1 shared paper)Indrajeet Singh Gambhir (1 shared paper)
- Journals
- Clinical and Experimental Hypertension (2 papers)Renal Failure (1 paper)Injury (1 paper)Journal of Thoracic and Cardiovascular Surgery (1 paper)The Journal of Laryngology & Otology (1 paper)
- Partner nations
- IndiaUnited KingdomJapan
In The Last Decade
M. Singh
17 papers receiving 532 citations
Peers
Comparison fields: 5 of 105
- Drug Discovery 1
- Materials Chemistry 205
- Complementary and alternative medicine 30
- Pediatrics, Perinatology and Child Health 59
- Biomaterials 32
Countries citing papers authored by M. Singh
This map shows the geographic impact of M. Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Singh more than expected).
Fields of papers citing papers by M. Singh
This network shows the impact of papers produced by M. Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Singh. The network helps show where M. Singh may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Singh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | NANOTECHNOLOGY IN MEDICINE AND ANTIBACTERIAL EFFECT OF SILVER NANOPARTICLES | 2008 | 253 |
| 2 | 2017 | 60 | |
| 3 | 2016 | 56 | |
| 4 | 2012 | 38 | |
| 5 | 1989 | 37 | |
| 6 | 2004 | 35 | |
| 7 | 2021 | 25 | |
| 8 | 2016 | 22 | |
| 9 | NANOTECHNOLOGY FOR ALZHEIMER'S DISEASE DETECTION | 2008 | 10 |
| 10 | Pharmacological basis of drug therapy of Alzheimer's disease. | 1997 | 9 |
| 11 | 2022 | 5 | |
| 12 | 1979 | 5 | |
| 13 | 2007 | 4 | |
| 14 | Alzheimer’s disease: A Threat to mankind | 2011 | 2 |
| 15 | 2013 | 2 | |
| 16 | 1986 | 2 | |
| 17 | 2020 | 2 | |
| 18 | 2023 | 0 |
About M. Singh
M. Singh is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Pediatrics, Perinatology and Child Health and Surgery, having authored 18 papers that have together received 567 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (2 papers), Renin-Angiotensin System Studies (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Blood Pressure and Hypertension Studies (2 papers), Neurological Complications and Syndromes (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Pharmacological Effects and Toxicity Studies (1 paper) and Abdominal Trauma and Injuries (1 paper). The work is most often cited by research in Drug Discovery (1 citation), Materials Chemistry (205 citations), Complementary and alternative medicine (30 citations), Pediatrics, Perinatology and Child Health (59 citations) and Biomaterials (32 citations). M. Singh has collaborated with scholars based in India, United Kingdom and Japan. Frequent co-authors include Saurabh R Prasad, P.C. Pándey, R. Peter Alston, Masabumi Nagashima, Yoshiro Inoue, Alok Kumar Singh, H. S. Shukla, Indrajeet Singh Gambhir, Mallika Tewari and Arvind Singh. Their work appears in journals such as Clinical and Experimental Hypertension, Renal Failure, Injury, Journal of Thoracic and Cardiovascular Surgery and The Journal of Laryngology & Otology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.